In 2016 the CDC Guideline for Prescribing Opioids for Chronic Pain was released with the goal of reducing rates of opioid use disorder (OUD) and overdose and encouraging use of effective opioid-alternatives for the management of chronic pain. In the first and second year following the Guidelines’ release, total day’s supply for opioid prescriptions were reduced by 4.7% and 9.8%, respectively, compared to the pre-Guideline period. However, misinterpretation and misapplication of guideline recommendations continues to pose health equity challenges and add frustration to patient-provider relationships. Updates to the aforementioned CDC Guidelines have been drafted to address these remaining barriers to safe, effective, and equitable pain management and will be released in late 2022.
In this recorded Risk Evaluation and Mitigation Strategy (REMS) webcast, faculty will review anticipated updates to the Guidelines and discuss how best to incorporate these updates into practice. The activity will also examine the underlying pathophysiologic mechanisms of pain, the identification and management of OUD, and strategies for educating patients about their pain and pain treatment options.
At the end of this CME/CE activity, participants should be able to:
This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please click here for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the US Food and Drug Administration (FDA).
Physicians, psychologists, dentists, physician associates (PAs), nurse practitioners (NPs), nurses, and pharmacists
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and mitigated any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process.
Dr. Goree reports the following financial relationships: Consultant: Abbott and Stratus Medical, LLC. Research Support: Mainstay Medical and SPR Therapeutics.
Dr. D’Arcy reports the following financial relationships: Advisory Board: AppliedVR, Inc.
Dr. Durham reports no financial relationships.
The following peer reviewer and CME Outfitters staff have no financial relationships:
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.